Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors

被引：0
|
作者：
Sander, Michael [1 ]
Stukalin, Igor [2 ]
Vallerand, Isabelle A. [3 ]
Goutam, Siddhartha [4 ]
Ewanchuk, Benjamin W. [1 ]
Meyers, Daniel E. [2 ]
Pabani, Aliyah [2 ]
Morris, Don [2 ]
Heng, Daniel Y. C. [2 ]
Cheng, Tina [2 ]
机构：
[1] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada
[2] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[3] Univ Calgary, Dept Dermatol, Calgary, AB, Canada
[4] Univ Alberta, Fac Med, Edmonton, AB, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27995
引用
收藏
页码：AB170 / AB170
页数：1
相关论文
共 50 条
  • [41] Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors
    Sonke, Eric
    Angeles, Arkhjamil
    Nguyen, Thao Phuong
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
    Asher, Nethanel
    Marom, Edith M.
    Ben-Betzalel, Guy
    Baruch, Erez Nissim
    Steinberg-Silman, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Markel, Gal
    ONCOLOGIST, 2019, 24 (05): : 640 - 647
  • [43] Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma
    Jindal, Vishal
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)
  • [44] Efficacy of immune checkpoint inhibitors for treating uveal melanoma metastases
    Oxenreiter, Monica
    Lane, Anne Marie
    Cohen, Justine V.
    Sullivan, Ryan J.
    Kim, Ivana K.
    Gragoudas, Evangelos S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [45] Evaluation of circular RNA profiling in metastatic melanoma patients treated with immune checkpoint blockade
    Luis Onieva, Juan
    Oliver, Javier
    Laborda-Illanes, Aurora
    Chica-Parrado, Maria Rosario
    Garrido-Aranda, Alicia
    Robles-Podadera, Cynthia
    Prieto, Daniel
    Gallego, Elena
    Sanchez, Alfonso
    Comino, Inaki
    De Luque, Vanessa
    Alvarez, Martina
    Jose Lozano, Maria
    Jimenez, Pedro
    Berciano-Guerrero, Miguel Angel
    Alba, Emilio
    Cobo, Manuel
    Barragan, Isabel
    CANCER RESEARCH, 2020, 80 (16)
  • [46] PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
    Gabrys, H. S.
    Basler, L.
    Burgermeister, S.
    Hogan, S.
    Ahmadsei, M.
    Pavic, M.
    Bogowicz, M.
    Vuong, D.
    Tanadini-Lang, S.
    Foerster, R.
    Kudura, K.
    Huellner, M.
    Dummer, R.
    Levesque, M. P.
    Guckenberger, M.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET-CT
    Dirnitrakopoulou-Strauss, Antonia
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (05) : 813 - 822
  • [48] Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
    Stukalin, Igor
    Navani, Vishal
    Gupta, Mehul
    Ruan, Yibing
    Boyne, Devon J.
    O'Sullivan, Dylan E.
    Meyers, Daniel E.
    Goutam, Siddhartha
    Sander, Michael
    Ewanchuk, Benjamin W.
    Brenner, Darren R.
    Suo, Aleksi
    Cheung, Winson Y.
    Heng, Daniel Y. C.
    Monzon, Jose G.
    Cheng, Tina
    ONCOLOGIST, 2023, 28 (09): : 812 - 822
  • [49] Is microsatellite-instability a prognostic factor in melanoma patients treated with immune-checkpoint inhibitors?
    Koeller, M.
    Berger, M.
    Eder, S.
    Richtig, G.
    Richtig, E.
    Pichler, M.
    Winter, G.
    Hoefler, G.
    Aigelsreiter, A.
    VIRCHOWS ARCHIV, 2018, 473 : S9 - S10
  • [50] Neutrophil to lymphocyte ratio (NLR) as a prognostic biomarker in melanoma patients treated with immune checkpoint inhibitors
    Oey, O.
    Wijaya, W.
    Khattak, M. A.
    Abed, A.
    Meniawy, T.
    Reid, A.
    Calapre, L.
    Millward, M.
    Gray, E. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S1686 - S1686
12345